Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

RTTNews | 588 days ago
Stocktwits
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

(RTTNews) - Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.

Fiscal 2023, the company continues to expect total revenue between $250 million and $260 million, with Cell Engineering revenue between $145 million and $150 million as well as Biosecurity revenue up to $110 million.

The company added that New Cell Programs are expected to be within the previously disclosed guidance range of 80 to 85 new Cell Programs added to the platform in 2023.

A business review, including a discussion of Ginkgo's platform services for large scale data generation and AI to enable biopharma R&D, will be featured in a presentation.

Tags: DNA
Stocktwits
read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 496 days ago
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1122 days ago
Target Q2 Down, Yet Beats Street, Backs FY25 View, Names Michael Fiddelke CEO; Shares Hit

Target Q2 Down, Yet Beats Street, Backs FY25 View, Names Michael Fiddelke CEO; Shares Hit

Shares of Target Corp. were losing around 11 percent in the pre-market activity on the NYSE, after the retail major reported Wednesday lower profit and comparable sales in its second quarter. However, earnings per share and top line beat market estimates, and the firm maintained its fiscal 2025 outlook. Separately, Target announced the appointment of Michael Fiddelke, chief operating officer,
RTTNews | 2h 36min ago
Indonesia Unexpectedly Cuts Interest Rate

Indonesia Unexpectedly Cuts Interest Rate

Indonesia's central bank eased its monetary policy unexpectedly on Wednesday in order to bolster economic growth amid inflation remaining well within the target range. The Bank Indonesia board, led by Governor Perry Warjiyo, decided to cut the BI rate by 25 basis points to 5.0 percent.
RTTNews | 3h 1min ago
Tools
Kalender Ekonomi
Jam pasar
Suku bunga
Kalender hari libur
Pasar Valas
Forex Volatility
Forex Correlation
Berita Forex
Analisis Forex
COT Data
Likuiditas
Kalkulator Forex
Forex Heat Map
Heatmap indikator
Komunitas
Komunitas
Sistems
Most Popular Systems
Strategies
Kontes
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviu
Pialang
Perusahaan Prop Trading
VPS Services
Signal Providers
EA Programming Services
Program Afiliasi
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Bursa Kripto
Kursus trading
Pialang
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions
Siaran Pers
Platform
Widget
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.